- Home
- PRME vs NNY Comparison
PRME vs NNY Comparison
Compare PRME & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRME
- NNY
- Stock Information
- Founded
- PRME 2019
- NNY 1987
- Country
- PRME United States
- NNY United States
- Employees
- PRME N/A
- NNY N/A
- Industry
- PRME Medicinal Chemicals and Botanical Products
- NNY Investment Managers
- Sector
- PRME Health Care
- NNY Finance
- Exchange
- PRME Nasdaq
- NNY Nasdaq
- Market Cap
- PRME 165.4M
- NNY 155.1M
- IPO Year
- PRME 2022
- NNY N/A
- Fundamental
- Price
- PRME $1.67
- NNY $8.14
- Analyst Decision
- PRME Buy
- NNY
- Analyst Count
- PRME 6
- NNY 0
- Target Price
- PRME $9.38
- NNY N/A
- AVG Volume (30 Days)
- PRME 2.7M
- NNY 50.9K
- Earning Date
- PRME 05-08-2025
- NNY 01-01-0001
- Dividend Yield
- PRME N/A
- NNY 4.04%
- EPS Growth
- PRME N/A
- NNY N/A
- EPS
- PRME N/A
- NNY N/A
- Revenue
- PRME $3,846,000.00
- NNY N/A
- Revenue This Year
- PRME $104.12
- NNY N/A
- Revenue Next Year
- PRME $196.78
- NNY N/A
- P/E Ratio
- PRME N/A
- NNY N/A
- Revenue Growth
- PRME 550.76
- NNY N/A
- 52 Week Low
- PRME $1.11
- NNY $7.58
- 52 Week High
- PRME $8.14
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- PRME 61.84
- NNY 45.81
- Support Level
- PRME $1.20
- NNY $8.06
- Resistance Level
- PRME $1.35
- NNY $8.79
- Average True Range (ATR)
- PRME 0.13
- NNY 0.29
- MACD
- PRME 0.06
- NNY -0.01
- Stochastic Oscillator
- PRME 79.43
- NNY 9.88
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.